Back to calculatorJoin the waitlist

Boehringer Ingelheim

Boehringer Ingelheim Cares Foundation Patient Assistance Program

Free BI diabetes meds (Jardiance / Synjardy / Glyxambi / Trijardy / Tradjenta / Jentadueto) for uninsured or Medicare Part D patients. 2026 income limit: ≤250% FPL = $39,900 single / $54,100 couple / $82,500 family of 4 (48 states; higher in AK/HI).

Doctor signature neededUninsured only

What you need to enroll

Your doctor needs to sign part of the application

This program requires a prescriber signature. The easiest path: download the application, bring it to your next appointment, and have the office fax it in for you.

Your copay

Free

Eligible patients pay $0. See the eligibility checklist below to confirm you qualify.

Download form for your doctor

Covered medications

  • Jardiance (empagliflozin)
  • Synjardy (empagliflozin + metformin HCl)
  • Synjardy XR (empagliflozin + metformin HCl extended-release)
  • Glyxambi (empagliflozin + linagliptin)
  • Trijardy XR (empagliflozin + linagliptin + metformin HCl extended-release)
  • Tradjenta (linagliptin)
  • Jentadueto (linagliptin + metformin HCl)
  • Jentadueto XR (linagliptin + metformin HCl extended-release)

Am I eligible?

Need a prescription?
Yes — written by a licensed prescriber for the medications below.
Insurance required?
Uninsured patients only — not for anyone with insurance.
State restrictions?
Available nationwide.
Income limits?
Yes — household income limits apply. Verify with the program.

Who qualifies

  • US resident, outpatient under US-licensed HCP
  • Uninsured OR Medicare Part D
  • Household income ≤ 250% FPL (Group 2 = all diabetes drugs)
  • Has a current BI Rx
  • Household includes applicant + spouse + children under 19 living with them

Accepted

  • US resident (or US territory), being treated as outpatient by US-licensed HCP
  • Uninsured OR has Medicare Part D coverage
  • Annual household income (before taxes) ≤ 250% FPL for diabetes drugs: $39,900 single / $54,100 couple / $82,500 family of 4 (48 states)
  • Has a BI Rx for a Group 2 medicine (Jardiance, Synjardy/XR, Glyxambi, Trijardy XR, Tradjenta, Jentadueto/XR)

Not accepted

  • Commercial drug insurance (uninsured-or-Medicare-Part-D only)
  • Household income above 250% FPL for the household size
  • Non-BI medications
  • Previously grandfathered enrollees who exceed the 250% FPL limit — removed effective 1/1/2026

How to apply

  1. Visit boehringer-ingelheim.com/us/about-us/sustainable-development/our-commitment/how-apply for the BI Cares application
  2. Patient and prescriber complete and sign the form together
  3. Phone: 1-800-556-8317 (CareConnect4Me / BI Cares helpline)
  4. Fax: 1-800-639-9118
  5. Mail: BI Cares Foundation, PO Box 66565, St. Louis, MO 63166-6565

Using it at the pharmacy

This is patient assistance — Boehringer Ingelheim ships your medication directly to you. No pharmacy handoff.

Terms & limits

Fills per year
4 fills per year, per covered drug
Renewal
Renew every year
Download form for your doctor

2026 income limits (Group 2 = all diabetes drugs, ≤250% FPL, 48 states): 1-person $39,900, 2-person $54,100, 3-person $68,300, 4-person $82,500, 5-person $96,700, 6-person $110,900. Alaska/Hawaii limits higher. SAME limit applies to uninsured AND Medicare Part D beneficiaries (this is a 2026 change — previously Medicare-only had stricter limits). All BI diabetes drugs are in Group 2. Group 1 (≤200% FPL) covers respiratory drugs only — not diabetes. NEW for 2026: previously grandfathered higher-income patients are removed from program effective 1/1/2026. Enrollment lasts 12 months from approval (Medicare Part D approved 10/15–12/31 lasts through 12/31 of following year, max 15 months). Document ID PC-US-148739 (1/2026).

Be first when we launch — we'll save these matches and remind you to renew.

Join the waitlist
Download form for your doctor